Compare
Odyssey Health, Inc. vs Global Innovative Platforms Inc. vs Stimcell Energetics Inc. vs Vycor Medical Inc
| Latest fiscal year | Odyssey Health, Inc. ODYY | Global Innovative Platforms Inc. GIPL | Stimcell Energetics Inc. STME | Vycor Medical Inc VYCO |
|---|---|---|---|---|
| Year ended | 2026-07-31 | 2025-09-30 | 2026-05-31 | 2025-12-31 |
| Revenue | n/a | $0 | n/a | $1.86M |
| Revenue growth (YoY) | n/a | n/a | n/a | +17.2% |
| Gross margin | n/a | n/a | n/a | 83.8% |
| Operating margin | n/a | n/a | n/a | 1.8% |
| Net margin | n/a | n/a | n/a | -3.9% |
| Net income | -$5.73M | -$718.3K | -$895.4K | -$72.4K |
| EPS (Diluted) | -$0.05 | -$0.02 | n/a | -$0.01 |
| Operating cash flow | -$1.05M | -$560.7K | -$312.1K | -$13.5K |
| Free cash flow | n/a | n/a | n/a | -$18.7K |
| Cash & equivalents | n/a | n/a | n/a | $87.0K |
| Total assets | $147.9K | $199.3K | $81.5K | $830.4K |
| Total liabilities | n/a | $11.6K | $1.89M | $4.92M |
| Shareholders' equity | -$12.13M | $187.7K | -$1.81M | -$4.09M |
| Return on year-end equity | n/a | -382.7% | n/a | n/a |
| Shares outstanding | 105.97M | 44.48M | n/a | 33.37M |
Revenue, most recent five fiscal years
| Fiscal year | Odyssey Health, Inc. | Global Innovative Platforms Inc. | Stimcell Energetics Inc. | Vycor Medical Inc |
|---|---|---|---|---|
| Latest | $0 Ended 2020-07-31 | $0 Ended 2025-09-30 | $0 Ended 2024-05-31 | $1.86M Ended 2025-12-31 |
| 1 year earlier | $0 Ended 2019-07-31 | $0 Ended 2024-09-30 | $2.8K Ended 2023-05-31 | $1.59M Ended 2024-12-31 |
| 2 years earlier | $0 Ended 2018-07-31 | $0 Ended 2023-09-30 | n/a | $1.46M Ended 2023-12-31 |
| 3 years earlier | $0 Ended 2017-07-31 | $0 Ended 2022-09-30 | n/a | $1.22M Ended 2022-12-31 |
| 4 years earlier | $37.5K Ended 2016-07-31 | $0 Ended 2021-09-30 | $95.8K Ended 2020-05-31 | $1.39M Ended 2021-12-31 |